Clinical Trials Logo

Filter by:
NCT ID: NCT06075511 Enrolling by invitation - Renal Failure Clinical Trials

A Study of Sleeve Gastrectomy Risks and Benefits

Start date: July 2024
Phase:
Study type: Observational

This research study is being conducted to collect information to improve the outcomes of patients who have renal failure and are scheduled to have a sleeve gastrectomy.

NCT ID: NCT06075446 Recruiting - Child Abuse Clinical Trials

Calling All Dads! Evaluation of APAs ACT Program: Engaging Fathers to Prevent Adverse Childhood Experiences

CAD
Start date: March 28, 2022
Phase:
Study type: Observational

The goal of this observational study is to assess the American Psychological Association's ACT Raising Safe Kids program with male caregivers. The main question[s] it aims to answer are: • Will male caregivers in the ACT Raising Safe Kids program report lower child maltreatment, rates of interpersonal violence, and youth aggression. • Does the ACT RSK program have a positive return on investment and will children and caregivers in the ACT RSK condition have a higher quality adjusted life years. Participants will complete four surveys over time and attend the 9-week ACT Raising Safe Kids program. Researchers will compare survey responses from male caregivers taking the ACT Raising Safe Kids classes to male caregivers not taking ACT Raising Safe Kids classes to see if there are changes in anger regulation, family conflict, parent-child conflict, and relationship satisfaction.

NCT ID: NCT06075329 Not yet recruiting - Loneliness Clinical Trials

Dementia Caregivers and Contemplative Practice: A Pilot Study

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The goal of this study is to test the contemplative practice is feasible and acceptable among informal dementia caregivers population at all stages.

NCT ID: NCT06075316 Recruiting - Thoracic Clinical Trials

Improving Thoracic Surgical Care Using Electronic Patient-Reported Outcomes (ePROS)

Start date: November 14, 2023
Phase: N/A
Study type: Interventional

This is a single-site, non-randomized study on the outcomes of remote real-time "ePRO monitoring" in thoracic surgery patients. ePRO monitoring is a health information technology intervention comprised of delivering longitudinal electronic patient-reported outcome (ePRO) surveys (e.g., on symptoms, and physical functioning) coupled with automated provider alerts for concerning survey responses.

NCT ID: NCT06075264 Recruiting - HPV Infection Clinical Trials

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)

ART-VIN IIB
Start date: December 6, 2023
Phase: Phase 2
Study type: Interventional

This is a phase II double-blind, placebo-controlled study of artesunate ointment for the treatment of HPV-associated vulvar HSIL (usual type vulvar intraepithelial neoplasia 2/3).

NCT ID: NCT06075095 Recruiting - Clinical trials for COPD (Chronic Obstructive Pulmonary Disease)

A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a New Propellant (HFO) in Participants 40 to 80 Years of Age With COPD

Start date: January 11, 2024
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate that the lung function effect from orally inhaled BGF delivered via HFO propellant is equivalent to the lung function effect from orally inhaled BGF delivered via HFA propellant in participants with COPD. The study duration for each participant will be approximately 15 to 16 weeks and consist of: 1. A screening and placebo run-in period of approximately 2 weeks prior to first dosing 2. Three treatment periods of approximately 4 weeks each (one period for each of 3 study interventions) 3. A final safety follow-up visit via telephone contact approximately 1 to 2 weeks after the final dose administration Participants will be provided with rescue SABA (albuterol or salbutamol) to be used as needed throughout the study. Participants will attend in-clinic study visits approximately weekly during the screening/run-in period (Visits 1, 2, and 3), then every 4 weeks (Visits 4, 5, and 6) to receive take-home study treatment, measure their lung function, and assess their health and safety

NCT ID: NCT06074926 Active, not recruiting - Pediatric Obesity Clinical Trials

Promoting Food Acceptance Through Positive Parenting: the Play and Grow Study

Start date: October 30, 2023
Phase: N/A
Study type: Interventional

Approximately one half of adults and one-fifth of children have obesity, including 14% of 2-5-year-olds. Early obesity prevention is essential as children who are overweight by age 5 are at increased risk for later obesity. Dietary intake is inextricably linked to weight status, and the majority of young children fail to meet intake recommendations, with socioeconomically disadvantaged and racial/ethnic minority children at increased risk of poor diet quality. However, children's liking of healthier foods predicts their intake, and children can learn to like healthier foods via experience. The current study brings together evidence from the parenting and learning literatures to: 1) examine effects of a novel learning strategy leveraging positive parent-child interactions on 3-5-year-old children's vegetable acceptance and dietary intake, as well as to explore 2) individual differences in learning strategy effects.

NCT ID: NCT06074666 Recruiting - Clinical trials for Acute Lymphoblastic Leukemia, Pediatric

Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The current study will assess the acceptability and feasibility of the CareMeds intervention with a larger sample (N = 100) across multiple sites in Buffalo, NY, and Atlanta, GA.

NCT ID: NCT06074627 Active, not recruiting - Fatigue Clinical Trials

Radicle Energy2: A Study of Health and Wellness Products on Fatigue and Other Health Outcomes

Start date: September 26, 2023
Phase: N/A
Study type: Interventional

A randomized, blinded, placebo-controlled study assessing the impact of health and wellness products on fatigue and other health outcomes

NCT ID: NCT06074601 Active, not recruiting - Preterm Birth Clinical Trials

MIRACLE of LIFE Study

MoL
Start date: August 1, 2021
Phase:
Study type: Observational

The goal of this observational study is to develop and validate cell-free RNA-based biomarkers for predicting a variety of adverse pregnancy outcomes in a pregnant person population. The main question it aims to answer are: 1. Can cell-free RNA-based biomarkers predict which pregnant people are at greatest risk of developing adverse pregnancy outcomes (e.g., preterm birth, preeclampsia)? 2. What is the performance of such biomarkers when predicting an adverse pregnancy outcome (e.g., sensitivity, specificity, PPV, NPV, TPR)?